Crohn's disease (CD) and ulcerative colitis (UC) are characterized by overexpression of
proinflammatory cytokines. We determined the association of serum levels of interleukin (IL) …

Abstract Purpose Interleukin-6 (IL-6) production and signalling are increased in the inflamed
mucosa in inflammatory bowel diseases (IBD). As published serum levels of IL-6 and its …

Background Cytokines are key mediators of the inflammation in ulcerative colitis (UC); there
are inconsistent data on cytokines profile in patients with UC. C‐reactive protein/albumin …

Background: Immunoregulatory properties of cytokines may mediate disordered
inflammatory events in inflammatory bowel diseases (IBDs). On the basis of data obtained in …

Interleukin-6 (IL-6) has a major function in the regulation of thc infiammatory process. We
aimed to define its role as a parameter of disease activity and extent in inflammatory bowel …

Crohn's disease (CD) and ulcerative colitis (UC) show an intestinal activation of T cells and
macrophages within the inflamed lesions. The aim of the present prospective study was to …

Objectives: Infliximab is effective in patients with ulcerative colitis (UC); however, one-third of
patients do not respond and require additional therapies such as other biologic agents …

SUMMARY Interleukin (IL)-1 is a key mediator in the pathogenesis of inflammatory bowel
disease (IBD). Naturally occurring IL-1 modulators include IL-1 receptor antagonist (IL-1Ra) …

AIM To evaluate circulating IL9 in inflammatory bowel disease and disease-associated
anemia/cachexia and assess its potential as a mucosal healing marker. METHODS Serum …

Interleukin-10 (IL-10) is a key anti-inflammatory cytokine, and it is associated with the
pathogenesis of inflammatory bowel disease (IBD). However, the relationship between …